Safety Evaluation of the Omnipod® 5 Automated Insulin Delivery System Over Three Months of Use in Children With Type 1 Diabetes (T1D)

Advances in diabetes technology have transformed the treatment paradigm for T1D, yet the burden of the disease remains significant. The pediatric population poses unique challenges to glucose management with unpredictable exercise and food consumption. The Omnipod 5 System is a novel hybrid closed-l...

Descripción completa

Detalles Bibliográficos
Autores principales: Buckingham, Bruce A, Forlenza, Gregory P, Criego, Amy B, Hansen, David W, Bode, Bruce W, Brown, Sue A, MacLeish, Sarah A, Pinsker, Jordan E, DeSalvo, Daniel J, Sherr, Jennifer L, Mehta, Sanjeev N, Laffel, Lori M, Bhargava, Anuj, Ly, Trang T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090047/
http://dx.doi.org/10.1210/jendso/bvab048.927

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090047/
http://dx.doi.org/10.1210/jendso/bvab048.927

Ejemplares similares